BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Prasad EM, Hung SY. Behavioral Tests in Neurotoxin-Induced Animal Models of Parkinson's Disease. Antioxidants (Basel) 2020;9:E1007. [PMID: 33081318 DOI: 10.3390/antiox9101007] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Li X, Hu X, Jiang Y, Wang D, Wang T, Li B. Autonomic behavioral impairment induced by simazine exposure during early life of male mouse is mediated by Lmx1a/Wnt1 pathway. Environ Toxicol 2021. [PMID: 34936186 DOI: 10.1002/tox.23442] [Reference Citation Analysis]
2 Çiğ B, Derouiche S, Jiang LH. Editorial: Emerging Roles of TRP Channels in Brain Pathology. Front Cell Dev Biol 2021;9:705196. [PMID: 34164407 DOI: 10.3389/fcell.2021.705196] [Reference Citation Analysis]
3 Vaccari C, Grotto D, Pereira TDV, de Camargo JLV, Lopes LC. GLP-1 and GIP receptor agonists in the treatment of Parkinson's disease: Translational systematic review and meta-analysis protocol of clinical and preclinical studies. PLoS One 2021;16:e0255726. [PMID: 34383800 DOI: 10.1371/journal.pone.0255726] [Reference Citation Analysis]
4 Athari SZ, Farajdokht F, Sadigh Eteghad S, Mohajeri D, Nourazar MA, Mohaddes G. Hydroxychloroquine attenuated motor impairment and oxidative stress in a rat 6-hydroxydopamine model of Parkinson's disease. Int J Neurosci 2022;:1-13. [PMID: 35522252 DOI: 10.1080/00207454.2022.2074848] [Reference Citation Analysis]
5 Ujvári B, Pytel B, Márton Z, Bognár M, Kovács LÁ, Farkas J, Gaszner T, Berta G, Kecskés A, Kormos V, Farkas B, Füredi N, Gaszner B. Neurodegeneration in the centrally-projecting Edinger-Westphal nucleus contributes to the non-motor symptoms of Parkinson's disease in the rat. J Neuroinflammation 2022;19:31. [PMID: 35109869 DOI: 10.1186/s12974-022-02399-w] [Reference Citation Analysis]
6 Tong ZW, Xie XH, Wang TT, Lu M, Jiao RH, Ge HM, Hu G, Tan RX. Acautalides A-C, Neuroprotective Diels-Alder Adducts from Solid-State Cultivated Acaulium sp. H-JQSF. Org Lett 2021;23:5587-91. [PMID: 34190564 DOI: 10.1021/acs.orglett.1c02089] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Dash PK, Gorantla S, Poluektova L, Hasan M, Waight E, Zhang C, Markovic M, Edagwa B, Machhi J, Olson KE, Wang X, Mosley RL, Kevadiya B, Gendelman HE. Humanized Mice for Infectious and Neurodegenerative disorders. Retrovirology 2021;18:13. [PMID: 34090462 DOI: 10.1186/s12977-021-00557-1] [Reference Citation Analysis]
8 Abuirmeileh AN, Abuhamdah SM, Ashraf A, Alzoubi KH. Protective effect of caffeine and/or taurine on the 6-hydroxydopamine-induced rat model of Parkinson's disease: Behavioral and neurochemical evidence. Restor Neurol Neurosci 2021;39:149-57. [PMID: 33998560 DOI: 10.3233/RNN-201131] [Reference Citation Analysis]
9 Motawi TK, Al-kady RH, Abdelraouf SM, Senousy MA. Empagliflozin alleviates endoplasmic reticulum stress and augments autophagy in rotenone-induced Parkinson's disease in rats: Targeting the GRP78/PERK/eIF2α/CHOP pathway and miR-211-5p. Chemico-Biological Interactions 2022. [DOI: 10.1016/j.cbi.2022.110002] [Reference Citation Analysis]
10 Prasad EM, Hung SY. Current Therapies in Clinical Trials of Parkinson's Disease: A 2021 Update. Pharmaceuticals (Basel) 2021;14:717. [PMID: 34451813 DOI: 10.3390/ph14080717] [Reference Citation Analysis]
11 González LF, Bevilacqua LE, Naves R. Nanotechnology-Based Drug Delivery Strategies to Repair the Mitochondrial Function in Neuroinflammatory and Neurodegenerative Diseases. Pharmaceutics 2021;13:2055. [PMID: 34959337 DOI: 10.3390/pharmaceutics13122055] [Reference Citation Analysis]